NO914859L - 3'-(2')-amino- eller tiolmodifiserte, fluorescensfarvestoffkoblede nukleosider, nukleotider og oligonukleotider, samt fremgangsmaate for fremstilling og anvendelse derav - Google Patents

3'-(2')-amino- eller tiolmodifiserte, fluorescensfarvestoffkoblede nukleosider, nukleotider og oligonukleotider, samt fremgangsmaate for fremstilling og anvendelse derav

Info

Publication number
NO914859L
NO914859L NO91914859A NO914859A NO914859L NO 914859 L NO914859 L NO 914859L NO 91914859 A NO91914859 A NO 91914859A NO 914859 A NO914859 A NO 914859A NO 914859 L NO914859 L NO 914859L
Authority
NO
Norway
Prior art keywords
amino
nucleotides
oigonucleotides
fluorescense
procedures
Prior art date
Application number
NO91914859A
Other languages
English (en)
Norwegian (no)
Other versions
NO914859D0 (no
Inventor
Joachim Engels
Mathias Herrlein
Renate Konrad
Matthias Mag
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO914859D0 publication Critical patent/NO914859D0/no
Publication of NO914859L publication Critical patent/NO914859L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91914859A 1990-12-11 1991-12-10 3'-(2')-amino- eller tiolmodifiserte, fluorescensfarvestoffkoblede nukleosider, nukleotider og oligonukleotider, samt fremgangsmaate for fremstilling og anvendelse derav NO914859L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4039488 1990-12-11

Publications (2)

Publication Number Publication Date
NO914859D0 NO914859D0 (no) 1991-12-10
NO914859L true NO914859L (no) 1992-06-12

Family

ID=6420050

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914859A NO914859L (no) 1990-12-11 1991-12-10 3'-(2')-amino- eller tiolmodifiserte, fluorescensfarvestoffkoblede nukleosider, nukleotider og oligonukleotider, samt fremgangsmaate for fremstilling og anvendelse derav

Country Status (27)

Country Link
US (3) US5679785A (pl)
EP (1) EP0490281B1 (pl)
JP (1) JP3140127B2 (pl)
KR (1) KR920012107A (pl)
AT (1) ATE142222T1 (pl)
AU (1) AU643856B2 (pl)
BG (1) BG61484B1 (pl)
BR (1) BR9105335A (pl)
CA (1) CA2057475A1 (pl)
CS (1) CS374391A3 (pl)
DE (1) DE59108143D1 (pl)
DK (1) DK0490281T3 (pl)
ES (1) ES2093671T3 (pl)
FI (1) FI915779A7 (pl)
GR (1) GR3021041T3 (pl)
HU (1) HUT60505A (pl)
IE (1) IE75726B1 (pl)
IL (1) IL100298A (pl)
MX (1) MX9102468A (pl)
NO (1) NO914859L (pl)
NZ (1) NZ240900A (pl)
PL (1) PL168874B1 (pl)
PT (1) PT99747A (pl)
RO (1) RO111575B1 (pl)
RU (1) RU2073682C1 (pl)
TR (1) TR27715A (pl)
YU (1) YU187991A (pl)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476925A (en) * 1993-02-01 1995-12-19 Northwestern University Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups
US5599922A (en) * 1994-03-18 1997-02-04 Lynx Therapeutics, Inc. Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties
US5726297A (en) * 1994-03-18 1998-03-10 Lynx Therapeutics, Inc. Oligodeoxyribonucleotide N3' P5' phosphoramidates
CZ274596A3 (en) * 1994-03-18 1997-03-12 Lynx Therapeutics Oligonucleotide n3 - p5 phosphoramidates and process of their synthesis and hybridization
DE4418691A1 (de) * 1994-05-28 1996-02-22 Boehringer Mannheim Gmbh 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer
US5962271A (en) * 1996-01-03 1999-10-05 Cloutech Laboratories, Inc. Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
US5684143A (en) * 1996-02-21 1997-11-04 Lynx Therapeutics, Inc. Oligo-2'-fluoronucleotide N3'->P5' phosphoramidates
US5859233A (en) * 1996-02-21 1999-01-12 Lynx Therapeutics, Inc. Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates
US6017702A (en) * 1996-12-05 2000-01-25 The Perkin-Elmer Corporation Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate
DE19741084A1 (de) * 1997-09-18 1999-03-25 Knoell Hans Forschung Ev Hochaffine Nukleinsäuremoleküle mit funktionellen Gruppen zur spezifischen Erkennung von Zielmolekülen, ihre Herstellung und Verwendung
US6289229B1 (en) 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
US6184347B1 (en) 1998-11-19 2001-02-06 Agilent Technologies Inc. Minimization of blooming in high-density arrays by using reactive wash reagents
US6761877B2 (en) * 2000-02-18 2004-07-13 Biocrystal, Ltd. Functionalized encapsulated fluorescent nanocrystals
CA2423806C (en) 2000-09-29 2009-12-22 Molecular Probes, Inc. Modified carbocyanine dyes and their conjugates
US7563618B2 (en) * 2001-03-23 2009-07-21 Geron Corporation Oligonucleotide conjugates
KR100762261B1 (ko) 2001-04-27 2007-10-04 (주)바이오니아 전장 상보 디옥시리보핵산 제조 방법과 이에 사용되는앵커와 프라이머
US7205048B2 (en) * 2001-09-17 2007-04-17 Invitrogen Corporation Functionalized fluorescent nanocrystal compositions and methods of making
US7214428B2 (en) * 2001-09-17 2007-05-08 Invitrogen Corporation Highly luminescent functionalized semiconductor nanocrystals for biological and physical applications
JP2005513471A (ja) * 2001-09-17 2005-05-12 バイオクリスタル・リミテッド ナノ結晶
WO2004055160A2 (en) * 2002-12-13 2004-07-01 The Trustees Of Columbia University In The City Of New York Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry
JP4177123B2 (ja) * 2003-01-10 2008-11-05 富士通株式会社 配線図形検証方法、プログラム及び装置
EP1611254B1 (en) 2003-03-31 2014-09-10 Roche Diagnostics GmbH Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
US20060172133A1 (en) * 2004-08-17 2006-08-03 Imad Naasani Synthesis of highly luminescent colloidal particles
ATE556126T1 (de) 2004-10-29 2012-05-15 Life Technologies Corp Funktionalisierte fluoreszierende nanokristalle und verfahren zu deren herstellung und verwendung
WO2006048262A2 (en) * 2004-11-04 2006-05-11 Roche Diagnostics Gmbh Classification of acute myeloid leukemia
US7541144B2 (en) * 2005-01-31 2009-06-02 Agilent Technologies, Inc. RNA labeling method
EP2230316A1 (en) 2005-02-01 2010-09-22 AB Advanced Genetic Analysis Corporation Nucleic acid sequencing by performing successive cycles of duplex extension
US7544471B2 (en) * 2005-07-30 2009-06-09 Agilent Technologies, Inc. Preparing RNA from a wax-embedded tissue specimen
US7700289B2 (en) * 2006-04-03 2010-04-20 Agilent Technologies, Inc. Method for labeling RNA
CN101495654A (zh) * 2006-04-19 2009-07-29 阿普里拉股份有限公司 无凝胶珠基测序的试剂、方法和文库
US7572585B2 (en) * 2006-07-31 2009-08-11 Agilent Technologies, Inc. Enzymatic labeling of RNA
RU2326888C1 (ru) * 2006-10-23 2008-06-20 Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (СО РАН) Способ получения солей 5'-трифосфатов дезоксирибо- и рибоолигонуклеотидов
KR101504640B1 (ko) * 2006-12-05 2015-03-20 레이저젠, 인코퍼레이티드 광절단가능 표지된 뉴클레오티드와 뉴클레오시드, 표지된 뉴클레오티드와 뉴클레오시드, 그리고 dna 염기서열분석에서 이들의 이용 방법
EP2185726B1 (en) 2007-08-06 2014-01-08 Orion Genomics, LLC Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
JP2009077712A (ja) 2007-09-11 2009-04-16 F Hoffmann La Roche Ag B−Rafキナーゼ阻害剤に対する感受性についての診断試験
JP2010539982A (ja) * 2007-10-01 2010-12-24 アプライド バイオシステムズ, エルエルシー チェイスライゲーション配列決定法
US20100086914A1 (en) * 2008-10-03 2010-04-08 Roche Molecular Systems, Inc. High resolution, high throughput hla genotyping by clonal sequencing
CA2751758A1 (en) 2009-02-11 2010-08-19 Orion Genomics Llc Combinations of polymorphisms for determining allele-specific expression of igf2
US8431416B2 (en) 2009-04-01 2013-04-30 Becton, Dickinson And Company Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates
US8309059B2 (en) * 2009-08-31 2012-11-13 Promega Corporation Reactive cyanine compounds
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
EP2576837B1 (en) 2010-06-04 2017-09-06 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
EP2768985B1 (en) 2011-10-21 2019-03-20 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
ES2413566B1 (es) 2011-12-14 2014-05-20 Fundación Pública Andaluza Progreso Y Salud Método de obtención de datos útiles para el diagnóstico y pronóstico de la hipoacusia neurosensorial.
CA2877094A1 (en) 2012-06-18 2013-12-27 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
EP2931922B1 (en) 2012-12-14 2018-10-17 Chronix Biomedical Personalized biomarkers for cancer
WO2014194113A2 (en) 2013-05-29 2014-12-04 Chronix Biomedical Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
DK3201361T3 (da) 2014-10-01 2020-05-18 Chronix Biomedical Fremgangsmåder til kvantificering af cellefrit DNA
WO2017172608A1 (en) 2016-03-28 2017-10-05 Aat Bioquest, Inc. Polyfluoreno[4,5-cde]oxepine conjugates and their use in methods of analyte detection
US11220628B2 (en) 2019-02-20 2022-01-11 Aat Bioquest, Inc. Condensed polycyclic conjugated polymers and their use for biological detection
CN115280147A (zh) 2020-01-30 2022-11-01 阿特生物探索公司 可紫外激发的基于聚芴的缀合物及其在分析物检测方法中的用途
US20250101412A1 (en) * 2022-01-25 2025-03-27 Oregon Health & Science University Methods and systems for increasing capture potential of a spatial array

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015733A (en) * 1983-12-20 1991-05-14 California Institute Of Technology Nucleosides possessing blocked aliphatic amino groups
US4849513A (en) * 1983-12-20 1989-07-18 California Institute Of Technology Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
EP0267996A1 (en) * 1986-11-20 1988-05-25 Tamir Biotechnology Ltd. New nucleotide derivatives
GB2236852B (en) * 1989-09-25 1994-04-06 Scotgen Ltd DNA probe based assays and intermediates useful in the synthesis of cleavable nucleic acids for use in such assays
US5227487A (en) * 1990-04-16 1993-07-13 Molecular Probes, Inc. Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
US5541307A (en) * 1990-07-27 1996-07-30 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs and solid phase synthesis thereof

Also Published As

Publication number Publication date
AU8892791A (en) 1992-06-18
IL100298A0 (en) 1992-09-06
YU187991A (sh) 1994-09-09
ATE142222T1 (de) 1996-09-15
EP0490281A1 (de) 1992-06-17
ES2093671T3 (es) 1997-01-01
AU643856B2 (en) 1993-11-25
JP3140127B2 (ja) 2001-03-05
MX9102468A (es) 1992-06-01
RU2073682C1 (ru) 1997-02-20
KR920012107A (ko) 1992-07-25
CS374391A3 (en) 1992-06-17
IE914301A1 (en) 1992-06-17
BR9105335A (pt) 1992-08-25
NO914859D0 (no) 1991-12-10
DK0490281T3 (pl) 1997-02-10
NZ240900A (en) 1994-07-26
HU913885D0 (en) 1992-02-28
CA2057475A1 (en) 1992-06-12
RO111575B1 (ro) 1996-11-29
EP0490281B1 (de) 1996-09-04
BG95575A (bg) 1993-12-24
FI915779A7 (fi) 1992-06-12
BG61484B1 (bg) 1997-09-30
PL292701A1 (en) 1992-09-21
IE75726B1 (en) 1997-09-24
PT99747A (pt) 1992-11-30
HUT60505A (en) 1992-09-28
FI915779A0 (fi) 1991-12-09
US5679785A (en) 1997-10-21
JPH04290896A (ja) 1992-10-15
DE59108143D1 (de) 1996-10-10
GR3021041T3 (en) 1996-12-31
US5659025A (en) 1997-08-19
PL168874B1 (pl) 1996-04-30
IL100298A (en) 1997-03-18
TR27715A (tr) 1995-06-22
US5668269A (en) 1997-09-16

Similar Documents

Publication Publication Date Title
NO914859L (no) 3'-(2')-amino- eller tiolmodifiserte, fluorescensfarvestoffkoblede nukleosider, nukleotider og oligonukleotider, samt fremgangsmaate for fremstilling og anvendelse derav
AU687801B2 (en) DNA sequencing by mass spectrometry via exonuclease degradation
DE69314951T2 (de) Dns sequenzierungsverfahren
JP3013156B2 (ja) 3’−固有の校正活性を有するdnaポリメラーゼの使用
DE69433811T2 (de) Dns - sequenzierung durch massenspektronomie
EP1725572B1 (de) Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
KR102749871B1 (ko) 폴리뉴클레오티드의 시퀀싱 방법
JP2006525022A5 (pl)
CN102317473A (zh) 核酸模板的分类
EP1415001A2 (en) Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
AU2002354577A1 (en) Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
EP3696275B1 (en) Method for improving loading and stability of nucleic acid on solid support
CA3139169A1 (en) Single-channel sequencing method based on self-luminescence
CA2243637A1 (en) Nucleoside analogues
Morel et al. In situ hybridization in light microscopy
Rosenthal et al. Automated sequencing of fluorescently labelled DNA by chemical degradation
DE102006012317A1 (de) Makromolekulare Nukleotidverbindungen und Methoden zu deren Anwendung
KR20240050459A (ko) 표적 폴리뉴클레오티드의 서열을 분석하기 위한 방법